DUBLIN, Calif., April 21 /PRNewswire-FirstCall/ -- SuperGen Inc. , a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies, today announced that it will release its 2008 first quarter financial results on Monday, April 28, 2008. SuperGen's management team will provide details of the Company's financial results and any revised outlook for the future.
A press release will be transmitted to the news media immediately following the close of the market on April 28, 2008. The Company will host a conference call and webcast to discuss the results at 4:30 p.m. ET / 1:30 p.m. PT. The webcast will be accessible via the Investor Relations section of the Company's Web site at www.supergen.com. A webcast replay of the live conference call will be available for 90 days.
About SuperGen
Based in Dublin, Calif., SuperGen Inc. is a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit http://www.supergen.com.
CONTACT: Timothy L. Enns, S.V.P., Corporate Communications & Business
Development, +1-925-560-0100, tenns@supergen.com, Mary M. Vegh, Manager,
Investor, Relations, +1-925-560-2845, mary.vegh@supergen.com, both of
SuperGen, Inc.
Web site: http://www.supergen.com/
